GQ1035: A First-in-Class Dual Payload ADC with Promising Preclinical Activity in Gastric Cancer
2:45 pm - Tuesday 9th March 2027
- Addressing unmet therapeutic needs in gastric cancer through a novel dual payload ADC strategy
- Demonstrating promising anti-tumour activity across multiple patient-derived xenograft (PDX) models of gastric cancer
- Translating preclinical efficacy and emerging biomarker insights into indication selection and future clinical development
